Pfizer Provides Tepid Outlook As Q4 Results Miss Expectations

From Pfizer Inc. (NYSE:PFE) early Tuesday posted disappointing fourth quarter results and offered a tepid outlook, amid weakening demand for some of its key drugs.
NYSE:PFE January 31, 2017 7:14am

Pfizer Shares Drop 3.5% As Earnings, Outlook Disappoint

pfizer-pfe-logoPharmaceutical giant Pfizer Inc. (NYSE:PFE) this morning posted mixed third quarter results and adjusted its full-year outlook, which will likely fall short of expectations.
NYSE:PFE November 1, 2016 7:43am

Pfizer Shares Retreat After Company Decides Against Break-Up

Drug making giant Pfizer Inc. (NYSE:PFE) has decided against splitting into two separate publicly-traded entities, ending a multi-year vetting process aimed at unlocking shareholder value.
NYSE:PFE September 26, 2016 7:53am

Pfizer’s Spending Spree Continues with a $725 Million Antibiotics Acquisition

pfizer-pfe-logoFrom Zacks Research: Drug giant Pfizer Inc. (NYSE:PFE) continued its recent spending spree today, acquiring a rival's international anti-infectives business.
NYSE:PFE August 24, 2016 8:24am

Pfizer Wins the Medivation Auction, Will Acquire Company for $14 Billion

According to the Financial Times, drug giant Pfizer Inc. (NYSE:PFE) is set to acquire biotech standout Medivation Inc (NASDAQ:MDVN) for $14 billion, in a move that would heavily bolster Pfizer's cancer treatment portfolio.
NYSE:PFE August 22, 2016 7:08am

Pfizer’s Earnings Were Good, but Not Quite Good Enough

biotech-dnaDrug giant Pfizer Inc. (NYSE:PFE) on Tuesday posted estimate-beating earnings results and reaffirmed its full-year outlook, but the shares lost ground in early trading after a prolonged run-up heading into the report.
NYSE:PFE August 2, 2016 7:44am

Get Free Updates

Join over 50,000 investors who get the latest news from!

Most Popular

From Our Partners

Explore More from

Free Daily Newsletter

Get daily ETF insights from our market experts. Never miss another important market development again! respects your privacy.

Best ETFs

We've rated and ranked nearly 2,000 ETFs and ETNs using our proprietary SMART Grade system.

View Top Rated ETFs

Best Categories

We've ranked dozens of ETF categories based on relative performance.

Best ETF Categories